ストックスクリーナーアプリを入手
26.05
2.26%
0.63
Cg Oncology Inc (CGON) 最新ニュース
CG Oncology’s Bladder Cancer Drug Shows Strong Clinical Data, Drives Optimism Despite Price Target Cut - MSN
H.C. Wainwright Reiterates a Buy on CG Oncology (CGON), Keeps the PT - Yahoo Finance
Piper Sandler initiates coverage of oncology companies - MSN
CG Oncology initiated with an Overweight at Piper Sandler - TipRanks
Technical Models Detect Momentum Build in CG Oncology Inc.Portfolio Return Report & Real-Time Price Movement Reports - classian.co.kr
Why CG Oncology Inc. stock attracts strong analyst attentionWeekly Stock Report & Growth Oriented Trading Recommendations - 선데이타임즈
Will CG Oncology Inc. stock go up soonJuly 2025 Macro Moves & Accurate Intraday Trade Tips - Newser
How CG Oncology Inc. stock performs during market volatilityGold Moves & High Accuracy Investment Signals - Newser
What MACD signals say about CG Oncology Inc.July 2025 Retail & Technical Pattern Alert System - Newser
CG Oncology price target lowered to $62 from $63 at BofA - MSN
Price Reversal in CG Oncology Inc. Traders Watch Closely2025 Valuation Update & Free Risk Controlled Daily Trade Plans - newsimpact.co.kr
Statistical indicators supporting CG Oncology Inc.’s strengthWeekly Trading Summary & Free Weekly Watchlist of Top Performers - Newser
Intraday pattern recognizer results for CG Oncology Inc.Trade Exit Summary & Verified Stock Trade Ideas - Newser
What moving averages say about CG Oncology Inc.2025 Support & Resistance & High Yield Stock Recommendations - Newser
Comparing CG Oncology Inc. in custom built stock radarsQuarterly Trade Report & Weekly Momentum Picks - Newser
How does CG Oncology Inc. score in quality rankings2025 Buyback Activity & AI Enhanced Trading Signals - thegnnews.com
What makes CG Oncology Inc. stock price move sharply2025 Year in Review & High Accuracy Investment Entry Signals - thegnnews.com
Using R and stats models for CG Oncology Inc. forecastingJuly 2025 Trade Ideas & Safe Swing Trade Setup Alerts - Newser
Does CG Oncology Inc. qualify in momentum factor screeningJuly 2025 Catalysts & Community Trade Idea Sharing Platform - Newser
What earnings revisions data tells us about CG Oncology Inc.Product Launch & Stepwise Trade Signal Implementation - Newser
Real time breakdown of CG Oncology Inc. stock performanceJuly 2025 Trends & Weekly Return Optimization Alerts - Newser
CG Oncology Inc. stock trend outlook and recovery pathTrade Risk Assessment & Growth Oriented Trading Recommendations - Newser
Q3 Earnings Forecast for CG Oncology Issued By HC Wainwright - Defense World
Cantor Fitzgerald Lowers Earnings Estimates for CG Oncology - Defense World
New Product Launches: Will They Boost CG Oncology Inc. Stock in 2025Stop Loss & Free AI Powered Buy and Sell Recommendations - Newser
ETF Analysts See 14% Upside for Humankind US Stock ETF - AInvest
CG Oncology, Inc. (NASDAQ:CGON) Given Average Recommendation of “Buy” by Brokerages - Defense World
CG Oncology’s Q2 2025: Clinical Advances and Legal Wins - The Globe and Mail
Analysts Conflicted on These NA Names: Tempus AI, Inc. Class A (TEM) and CG Oncology, Inc. (CGON) - The Globe and Mail
CG Oncology Inc. Attempts Reversal From Key SupportExpert Verified Stock Trade Ideas Backed by Data - beatles.ru
CG Oncology 2025 Q1 Earnings Net Loss Widens Sharply - AInvest
Zurcher Kantonalbank Zurich Cantonalbank Acquires 7,600 Shares of CG Oncology, Inc. (NASDAQ:CGON) - Defense World
Buy Rating for CG Oncology, Inc. Driven by Promising Clinical Data and Strategic Advancements - NewsBreak: Local News & Alerts
CG Oncology shares rise 1.64% intraday after reporting positive earnings and clinical trial results. - AInvest
CG Oncology Reports Q2 GAAP EPS of -$0.54, Cash Holdings at $661.1 Million - AInvest
CG Oncology's Q2 2025: Balancing Burn Rate and Breakthroughs in the Race for Bladder Cancer Innovation - AInvest
CG Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2025 - MarketScreener
Cg Oncology (CGON) Q2 Loss Widens 93% - The Motley Fool
Cg Oncology (CGON) Q2 Loss Widens 93% - Nasdaq
Earnings Flash (CGON) CG Oncology Posts Q2 Net Loss $0.54 a Share, vs. FactSet Est of $0.46 Loss - MarketScreener
CG Oncology reports Q2 EPS (54c), consensus (44c) - TipRanks
CG Oncology Reports Q2 Financials, Announces BOND-003 Durability Data. - AInvest
CG Oncology Reports Second Quarter 2025 Financial Results and Provides Business Updates - The Globe and Mail
How King & Spalding Beat $2B Claim In Biopharma Fight - Law360
CG Oncology (CGON) Projected to Release Earnings on Thursday - Defense World
Is CG Oncology Inc. a good long term investmentSuperior return velocity - Jammu Links News
Does CG Oncology Inc. stock perform well during market downturnsGet ahead with breakthrough trading ideas - Jammu Links News
What analysts say about CG Oncology Inc. stockInvest confidently with real-time market updates - Jammu Links News
How does CG Oncology Inc. generate profit in a changing economyBreakthrough profit margins - Jammu Links News
CG Oncology, Inc. (CGON) Reports 75.5% Complete Response in Bladder Cancer Trial - MSN
When is CG Oncology Inc. stock expected to show significant growthInvest confidently with real-time data analysis - Jammu Links News
What are the latest earnings results for CG Oncology Inc.Breakthrough investment results - Jammu Links News
Should I hold or sell CG Oncology Inc. stock in 2025Discover stocks with explosive potential - Jammu Links News
How strong is CG Oncology Inc. company’s balance sheetUnlock expert market analysis instantly - Jammu Links News
What is the risk reward ratio of investing in CG Oncology Inc. stockInvest smarter with advanced market data - Jammu Links News
How to interpret RSI for CG Oncology Inc. stockStock Entry Point Planner with Volume Spike - Newser
Applying big data sentiment scoring on CG Oncology Inc.Free Weekly Setup With 3x Return Potential - Newser
1.01%
0.37%
大文字化:
|
ボリューム (24 時間):